Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119811) titled 'Evaluation of Therapeutic Efficacy of Different Doses of GnRH-a in the Treatment of Adenomyosis' on March 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Adenomyosis
Intervention:
Group A:A 10.8 mg goserelin acetate sustained-release implant is subcutaneously injected every 12 weeks, and a total of 2 injections are given according to the patients condition
Group B:A 3.6 mg goserelin acetate sustained-release implant is subcutaneously injected every 4 weeks, and a total of 6 injections are given according to the pa...